Robert Diasio News Today

The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.

One January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died in excruciating pain from the very drug meant to

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

Fluorouracil can be deadly for patients who slowly metabolize it. But U.S. doctors don't often test for those at risk.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.

A recent survey found that only 3% of U.S. oncologists routinely order the tests before dosing patients.